AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2015

Aug 21, 2015

30071_dirs_2015-08-21_a0f127a8-e023-455e-85b8-f73bb6d6780e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-08-19

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-19	ResMed Common Stock	A	49930	—	Acquired	172369.946	Direct

Footnotes

F1: Represents performance-based restricted stock units initially granted on November 19, 2014. The shares were earned on August 19, 2015, when the compensation committee certified that the performance metrics had been met.